Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study
Open Access
- 3 December 2025
- journal article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 46, 101056
Abstract
No abstract availableKeywords
Funding Information
- MSD
This publication has 35 references indexed in Scilit:
- Access to novel cancer medicines in Europe: inequities across countries and their driversESMO Open, 2025
- Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME databaseJournal of Geriatric Oncology, 2024
- Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)International Journal of Cancer, 2024
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyAnnals of Oncology, 2021
- Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the USJAMA Oncology, 2021
- Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)Lung Cancer, 2021
- Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave outCancer Treatment Reviews, 2019
- Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance TherapyThe Patient - Patient-Centered Outcomes Research, 2018
- Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physiciansClinical and Translational Oncology, 2012